Loading…
Loading…
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing i
On September 03, 2026, Park Hotels and Resorts Inc (PK) shares fell 3.1%, closing at $15.08. The stock has traded within a 52-week range of $9.84 to $16.20. GF V
[url="]Stoke Therapeutics, Inc.[/url] (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with
High-yield REITs with strong dividend security remain attractive despite rising Treasury yields and recent share price gains. Only seven REITs currently offer yields above 5.75% with reasonable to strong dividend safety, as rising share prices and treasury yields compress spreads. Dividend strength, as measured by Seeking Alpha Quant Ratings, is primarily supported by low debt, conservative payout ratios, and sector-relative revenue growth.
Jupiter Topco LLC bought a new stake in shares of Park Hotels and Resorts Inc. (NYSE: PK) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 296,726 shares of the financial services provider's stock, valued at approximately $4,230,000. Jupiter Topco LLC
Jupiter Topco LLC bought a new stake in shares of Park Hotels and Resorts Inc. (NYSE: PK) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 296,726 shares of the financial services provider's stock, valued at approximately $4,230,000. Jupiter Topco LLC
Park Hotels & Resorts delivered a 41% total return in four months, validating my prior 'Buy' rating. PK raised full-year 2026 guidance for the second consecutive quarter, with AFFO now expected at $1.90–$2.00/share and robust RevPAR growth. Non-core asset disposals are progressing slower than anticipated, but PK's balance sheet risk has eased with a $700M delayed-draw facility.
Park Hotels & Resorts: A Leaner Portfolio Starts Paying Off